Kotak Healthcare Fund
The fund maintains a heavily concentrated pharmaceutical focus, with over 71% in drugs and biotech while hospitals command just over a quarter of the portfolio. Sun Pharma's outsized 14% position signals conviction in large-cap stability, though the top ten stocks consuming 57% of assets suggests limited diversification within the healthcare theme. Recent additions of diagnostic players and Mankind Pharma's increased weight indicate the manager is broadening exposure toward higher-growth segments while trimming larger-cap pharma exposure, reflecting cautious optimism on mid-tier healthcare franchises.
Portfolio analysis · April 2026
NAV & Returns
| Plan | NAV | 1M | 1Y | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|---|
| Direct Growth | ₹15.5380 | — | — | — | — |
| Regular Growth | ₹14.9320 | +10.35% | +14.29% | — | — |
| Direct IDCW | ₹15.5360 | — | — | — | — |
| Regular IDCW | ₹14.9370 | — | — | — | — |
Portfolio Metrics(latest month)
vs Category Peers
Highly DifferentiatedActive Share = ½Σ|wfund − wpeer|, computed using leave-one-out peer portfolio within SEBI category.
Similar Funds in Category
What Changed2026-03-31 → 2026-04-30
| Stock | Weight |
|---|---|
| DR.Lal Pathlabs Ltd | 1.21% |
| METROPOLIS HEALTHCARE LTD. | 0.76% |
Full Holdings
| # | Holding | % to NAV |
|---|---|---|
| 1 | SUN PHARMACEUTICAL INDUSTRIES LTD. INE044A01036 | 14.04% |
| 2 | JB Chemicals & Pharmaceuticals Ltd. INE572A01036 | 6.63% |
| 3 | Max Healthcare Institute Ltd. INE027H01010 | 6.31% |
| 4 | Divis Laboratories Ltd. INE361B01024 | 5.90% |
| 5 | Fortis Healthcare India Ltd INE061F01013 | 4.84% |
| 6 | Ami Organics Ltd INE00FF01025 | 4.60% |
| 7 | Cipla Ltd. INE059A01026 | 4.22% |
| 8 | PARK MEDI WORLD LIMITED (PARK HOSPITAL) INE119201023 | 3.79% |
| 9 | KRISHNA INSTITUTE OF MEDICAL INE967H01025 | 3.56% |
| 10 | Apollo Hospitals Enterprise Ltd. INE437A01024 | 3.08% |
| 11 | Lupin Ltd. INE326A01037 | 3.02% |
| 12 | SAI LIFE SCIENCES LIMITED INE570L01029 | 3.02% |
| 13 | MANKIND PHARMA LTD INE634S01028 | 2.72% |
| 14 | Aurobindo Pharma Ltd. INE406A01037 | 2.64% |
| 15 | JUBILANT PHARMOVA LIMITED INE700A01033 | 2.52% |
| 16 | ANTHEM BIOSCIENCES LTD INE0CZ201020 | 2.45% |
| 17 | Glenmark Pharmaceuticals Ltd INE935A01035 | 2.43% |
| 18 | Ajanta Pharma Ltd. INE031B01049 | 2.39% |
| 19 | Alkem Laboratories Ltd. INE540L01014 | 2.07% |
| 20 | RUBICON RESEARCH LIMITED INE506V01022 | 1.96% |
Sector Allocation
Top 10 sectors by % to NAV. Excludes derivatives.
Frequently Asked Questions
How many stocks does Kotak Healthcare Fund hold?
Kotak Healthcare Fund holds 33 stocks as per the latest AMFI portfolio disclosure. The top 5 positions account for 37.72% of NAV.
What is the largest holding in Kotak Healthcare Fund?
The largest position in Kotak Healthcare Fund is SUN PHARMACEUTICAL INDUSTRIES LTD., accounting for 14.04% of NAV in the Pharmaceuticals and Biotechnology sector.
Is Kotak Healthcare Fund a concentrated or diversified fund?
With a Gini coefficient of 0.382, Kotak Healthcare Fund is well-diversified. The HHI concentration index is 50,373 bps, which is above the 2500 bps threshold for high concentration. The top 5 holdings together make up 37.72% of the portfolio.
What is the market cap allocation of Kotak Healthcare Fund?
Based on SEBI's AMFI classification, Kotak Healthcare Fund's equity portfolio is split as: Large Cap: 33.55%, Mid Cap: 21.43%, Small Cap: 44.04%. This reflects the fund's positioning within the market cap spectrum.
Which sectors does Kotak Healthcare Fund invest in most?
Kotak Healthcare Fund has the highest allocation to Pharmaceuticals and Biotechnology (71.52%), Healthcare Services (26.13%), Healthcare Equipment and Supplies (1.14%). The fund is invested across 4 sectors in total.
How actively managed is Kotak Healthcare Fund compared to other Sectoral / Thematic funds?
Kotak Healthcare Fund has an Active Share of 90.67%, classifying it as "Highly Differentiated" among 237 Sectoral / Thematic peers. This means the fund takes significantly different stock positions compared to its category peers.
What changed in Kotak Healthcare Fund's portfolio in the latest month?
Between 2026-03-31 and 2026-04-30, Kotak Healthcare Fund added 2 new stocks (including DR.Lal Pathlabs Ltd) and exited 1 stock (including Dr.Reddy's Laboratories Ltd.). Total holding count increased from 34 to 35 stocks.